BSK22-562 Observational basket trial to predict response to immune checkpoint inhibitors across solid tumors using a live tumor diagnostic platform (CYBRID-02)

NCT05520099

Observational basket trial to predict response to immune checkpoint inhibitors across solid tumors using a live tumor diagnostic platform (CYBRID-02)

Principal Investigator

Mark A. Socinski, MD

Sponsor

Elephas Corporation

This study is currently enrolling.

Online Form - Interest in Trial